Please login to the form below
treatment access
This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.
UK’s NICE recommends Roche’s Evrysdi
Most people with the severest form of the condition, type 1, die before the age of two without treatment. ... administration needs to the NHS In practical terms, the availability of an oral drug should lead to greater adherence to treatment, along with
Latest news
-
ICER to review the role of health insurers in determining patient access to prescription drugs
Non-profit research institute will evaluate how health insurance policies may harm patient access to treatment. ... yesterday. The first annual assessment into how health insurance policies may harm patient access to treatment will seek input from
-
Italy accelerates the path towards digital therapeutics implementation
resulted in the ongoing evolution of healthcare towards digital, personalised and accessible treatment. ... new therapeutic treatments that will mark the future of medicine, with a crucial impact on patients in terms of access to treatment and the
-
Novartis and NHS England reach ‘landmark’ deal for Zolgensma gene therapy for SMA
Novartis Gene Therapies and NHS England have reached a ‘landmark’ deal for Zolgensma gene therapy that gives patients with spinal muscular atrophy (SMA) access to the innovative treatment. . ... The managed access agreement for Spinraza that was
-
UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
diagnosis and treatment of rare diseases. ... Improved access to specialist care, treatment and drugs for rare diseases.
-
Full impact of COVID-19 pandemic on cancer treatment unknown, according to GlobalData
It is still too early to assess the full impact of the COVID-19 pandemic on both cancer treatment and development, according to GlobalData. ... In the long term, the pandemic may have a number of far-reaching consequences on the cancer treatment
More from news
Approximately 1 fully matching, plus 224 partially matching documents found.
Latest Intelligence
-
EU cross-border healthcare
Patients whose very survival depends on therapies that can only be delivered abroad must face a flurry of challenges to access the treatment that will hopefully change their lives forever. ... Furthermore, both pathways are impacted by several challenges
-
Could the rare disease community teach pharma a lesson?
by Leigh Ansell. Patient support programmes (PSPs) provide help, information and advice to patients, from diagnosis through treatment. ... They get involved with patient organisations, from fundraising and events to advocacy for research funding and
-
Rare genetic diseases – what’s in store for 2021?
The cross-collaboration has also brought forward fundamental changes and breakthroughs for the treatment of many rare genetic diseases. ... We’re looking at digital advances that would improve access to treatment and the overall patient experience.
-
New truths and realities in these strange times
The issue may be as simple as not being able to access their physician/GP in the usual manner, not having the usual access to their medications as regularly (if at ... Patients are also worried about access to care or treatment; the difficulties of
-
Great expectations: the urgent need for common purpose in Alzheimer’s disease
It will take multiple evolutions before we get an AD treatment equivalent to today’s smartphones. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.
More from intelligence
Approximately 1 fully matching, plus 54 partially matching documents found.
Latest appointments
-
UN names special envoy for HIV/ AIDS in Africa
Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
-
Basilea's Hans Christian Rohde takes up commercial role at uniQure
access to this crucial treatment to as many patients as possible.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Rethinking our approach to rare disease communications during COVID-19 and beyond
What support is available to them and their patients to ensure continued access to a given treatment. ... What the potential risks of home-based treatment administration and monitoring are, and how they can be mitigated.
-
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
4. Treatment pathway profiling. 6. Virtual and hybrid medical education programs (pre-launch). ... Access the full article here to learn more!
-
Living with psoriasis: a patient perspective
For those living with it, navigating a complex treatment pathway, with limited access to specialist dermatologists[ii] and whilst managing flare-ups, are significant challenges to achieving long-term goals. ... Activating people living with psoriasis to
-
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
Access to care and treatment. Access to research. Financial burden. Despite scientific development, greater healthcare awareness and technological advancements, time to diagnosis remains a significant challenge for people living with rare
-
If our patients are diverse, why are clinical trials so white?
As a result, it’s very likely that only wealthier people from urban areas will begin their treatment journey at these larger research institutions with the proper resources for and access ... Ninlaro is an oral treatment for multiple myeloma indicated
Living with psoriasis: a patient perspective
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
-
B2B media account director
-
Competitive salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Merck enters agreement with Hanmi for investigational NASH drug
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Novo Nordisk growth takes a hit with China deal
PMHub
Genetic Digital
Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...
Latest intelligence
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
